{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:55Z","timestamp":1791583195606,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T00:00:00Z","timestamp":1515801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ymthe.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T19:29:27Z","timestamp":1517340567000},"page":"814-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a"],"prefix":"10.1016","volume":"26","author":[{"given":"Daniel S.","family":"Roseman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayeba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Rajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy S.","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtika H.","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleo","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah D.","family":"Farelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romesh R.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.01.006_bib1","doi-asserted-by":"crossref","first-page":"21482","DOI":"10.1016\/S0021-9258(20)80563-8","article-title":"Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A","volume":"268","author":"Shelly","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.01.006_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-6-27","article-title":"Glucose-6-phosphatase deficiency","volume":"6","author":"Froissart","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2018.01.006_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","article-title":"Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease","volume":"38","author":"Rajas","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2018.01.006_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-\u03b2 deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymthe.2018.01.006_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1469-1809.1999.6320141.x","article-title":"Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a","volume":"63","author":"Bruni","year":"1999","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymthe.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr. Mol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1007\/BF02680007","article-title":"Guidelines for management of glycogen storage disease type I\u2014European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymthe.2018.01.006_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/hmg\/ddu746","article-title":"Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice","volume":"24","author":"Clar","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.01.006_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.mt.6300188","article-title":"Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia","volume":"15","author":"Koeberl","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.01.006_bib10","first-page":"28","article-title":"Minimal hepatic glucose-6-phosphatase-\u03b1 activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia","volume":"3","author":"Lee","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2018.01.006_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jpeds.2011.02.031","article-title":"Natural history of hepatocellular adenoma formation in glycogen storage disease type I","volume":"159","author":"Wang","year":"2011","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2018.01.006_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","article-title":"Hepatocellular carcinoma in glycogen storage disease type Ia: a case series","volume":"28","author":"Franco","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","article-title":"Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I","volume":"58","author":"Calderaro","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2018.01.006_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1074\/jbc.275.2.828","article-title":"Correction of glycogen storage disease type 1a in a mouse model by gene therapy","volume":"275","author":"Zingone","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","article-title":"Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-\u03b1 activity restored are at risk of developing hepatic tumors","volume":"120","author":"Kim","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2018.01.006_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2009.157","article-title":"Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia","volume":"21","author":"Weinstein","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.01.006_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/gt.2011.86","article-title":"Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia","volume":"19","author":"Crane","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/hum.2011.106","article-title":"Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia","volume":"23","author":"Demaster","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2013.03.018","article-title":"Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia","volume":"109","author":"Brooks","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/rmv.1762","article-title":"Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them","volume":"23","author":"Hareendran","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.01.006_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/cbic.201500205","article-title":"A recombinant collagen-mRNA platform for controllable protein synthesis","volume":"16","author":"Sun","year":"2015","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ymthe.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.08.014","article-title":"Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas","volume":"54","author":"Mutel","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2018.01.006_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-9-47","article-title":"Liver transplantation in glycogen storage disease type I","volume":"9","author":"Boers","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.01.006_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0021-9258(18)66180-0","article-title":"A microcolorimetric method for the determination of inorganic phosphorus","volume":"202","author":"Taussky","year":"1953","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:51:21Z","timestamp":1761501081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1525001618300133"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.01.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}